Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
2024 brought important results advances in medicine.
This includes the approval of “innovative” drugs such as Tryvio for high blood pressure, Neffy for severe allergic reactions and Dupixent for chronic obstructive pulmonary disease (COPD), all of which received FDA approval this year.
These medicines “are set to have a major clinical impact on those who need them,” according to GoodRx, a California-based digital health platform.
WHAT ARE PRESCRIPTION DRUGS CALLED? A DRUG DEVELOPMENT EXPERT SHARES THE PROCESS
Earlier this month, GoodRx released a list of the 19 most influential drugs and vaccine permits 2024, some newly developed to treat certain diseases and other existing drugs that have been approved for additional use.
Here is a list in order of FDA approval date.
1. Dupixent – Additional uses: eosinophilic esophagitis (an allergic condition that causes inflammation of the esophagus)
2. Amtagvi – New medicines: Advanced melanoma
3. Xolair – Additional use: Food allergy
THE 7 TOP QUESTIONS TO GOOGLE ABOUT HEALTH IN 2024 WITH ANSWERS OF EXPERTS
4. Vegs – Additional uses: Reduction of cardiovascular risk
5. Trivia – New medications: high blood pressure
6. Nexletol – Additional uses: high cholesterol
7. Winrevair – New drug: pulmonary arterial hypertension
8. mRESVIA – New vaccine: RSV
9. Capvaxive – New vaccine: Pneumococcal disease
10. Vakiks – Additional use: pediatric narcolepsy
5 MAIN DISCOVERIES BY SCIENTISTS IN 2024.
11. It is dangerous – New medicines: COPD
12. Kitty – New medicines: Alzheimer’s disease
13. Visually – Additional use: Heartburn from non-erosive GERD (gastroesophageal reflux disease)
14. Zunveil – New drugs: Alzheimer’s disease
15. Yorvipat – New drugs: hypoparathyroidism (low levels of parathyroid hormone)
For more health articles visit www.foxnews.com/health
16. Nephi – New medicines: Heavy allergic reactions
17. FluMist – Additional use: self-administration or administration by a guardian
CLICK HERE TO SUBSCRIBE TO OUR HEALTH NEWSLETTER
18. Kobenfi – New drugs: Schizophrenia
19. Dupixent – Additional use: COPD
In a disclaimer, GoodRx noted that the list was created by prioritizing “first-in-class drugs and vaccines that are expected to have a significant impact on human health.”
“This was determined by either the number of lives affected or the expected degree of impact on future recipients of the medication,” the company wrote.
“We also prioritized drugs with efficacy or safety data that were demonstrably superior to other drugs recommended by clinical treatment guidelines or major medical organizations.”
CLICK HERE TO GET THE FOX NEWS PROGRAM
Fox News Digital has reached out to GoodRx for comment.